Tech Company Financing Transactions
CoviCept Therapeutics Funding Round
CoviCept Therapeutics, based in San Diego, secured $2.3 million from Forbion Capital Partners.
Transaction Overview
Company Name
Announced On
1/20/2021
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Diego, CA 22434
USA
San Diego, CA 22434
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
CoviCept Therapeutics, Inc. is a newly founded company based in San Diego, USA, focused on the development of a small molecule that inhibits the replication and spread of RNA viruses, including SARS-Cov-2.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Sotirios Tsimikas
Browse more venture capital transactions:
Prev: 1/20/2021: Superchat venture capital transaction
Next: 1/21/2021: Apricus Health venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs